Susquehanna International Group’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,560
| Closed | -$600K | – | 6109 |
|
|
2020
Q4 | $600K | Sell |
4,560
-362
| -7% | -$47.6K | ﹤0.01% | 3203 |
|
|
2020
Q3 | $249K | Sell |
4,922
-35,627
| -88% | -$1.8M | ﹤0.01% | 3722 |
|
|
2020
Q2 | $1.93M | Buy |
40,549
+34,915
| +620% | +$1.66M | ﹤0.01% | 1497 |
|
|
2020
Q1 | $276K | Buy |
+5,634
| New | +$276K | ﹤0.01% | 3506 |
|
|
2019
Q4 | – | Sell |
-23,003
| Closed | -$827K | – | 5155 |
|
|
2019
Q3 | $827K | Buy |
+23,003
| New | +$827K | ﹤0.01% | 2261 |
|
|
2018
Q4 | – | Sell |
-11,764
| Closed | -$117K | – | 5285 |
|
|
2018
Q3 | $117K | Buy |
+11,764
| New | +$117K | ﹤0.01% | 2917 |
|